PIOZ MF 15 MG TAB

1. All Details: Specifications
Active Pharmaceutical Ingredients: Pioglitazone Hydrochloride IP and Metformin Hydrochloride IP.
Dosage Form: Uncoated bilayer/combination tablet featuring a sustained-release (SR) layer.
Coloring Agents: Yellow Oxide of Iron.
Storage Environment: Store below 25°C. Protect from moisture.
Legal / Drug Class Warnings: * Schedule H Prescription Drug – Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
Schedule G Prescription Drug – Caution: It is dangerous to take this preparation except under Medical Supervision.
Batch Identification: 28028017
Date of Manufacture (MFG. DATE): 03/2026
Date of Expiration (EXPIRY DATE): 02/2028
Maximum Retail Price (M.R.P.): Rs. 159.75 per 10 Tablets (Inclusive of all taxes).
2. General Information
Brand: PIOZ MF-15
Name: Pioglitazone Hydrochloride & Metformin Hydrochloride (SR) Tablets
Quantity: Strip of 10 Tablets (indicated by “10 Tablets” and “159.75/10 TABS”).
Type: Prescription Oral Anti-Diabetic Medication.
Factor (Form Factor): Solid oral tablet (Sustained Release).
Maximum Shelf Life: 23 months (From March 2026 to February 2028).
Food Preference: Not Applicable. This is an essential pharmaceutical medicine, so standard dietary classifications (such as green/brown food dots) are not used.
FSSAI: Not Applicable. This therapeutic agent is governed under the Drugs and Cosmetics Act by the CDSCO, meaning it does not fall under the purview of the FSSAI (Food Safety and Standards Authority of India).
3. Product Details: Ingredients
Each uncoated tablet contains:
Pioglitazone Hydrochloride IP equivalent to Pioglitazone: 15 mg
Metformin Hydrochloride IP (in Sustained release form): 500 mg
Excipients: q.s. (Quantity Sufficient)
4. Directions: How to Use
Dosage: As directed by the Physician.
Administration: Swallow the tablet whole with a glass of water, typically with or after meals to minimize gastrointestinal discomfort. Because a portion of this tablet is in a sustained-release (SR) formulation matrix, do not crush, chew, or break it, as doing so will disrupt the controlled, long-lasting delivery of the medication.
5. Description
Pioz MF-15 is a dual-action oral anti-diabetic medication used primarily for the management of Type 2 Diabetes Mellitus. It combines two complementary mechanisms: Pioglitazone (a thiazolidinedione that improves insulin sensitivity) and Metformin (a biguanide that reduces hepatic glucose production and delays intestinal glucose absorption) in a sustained-release delivery format. The packaging features clear statutory warning labels highlighting that it is a controlled substance requiring strict, ongoing monitoring by a qualified medical practitioner.
6. Manufacturer Information
Mfd. by: USV Private Limited
Plant Address: Plot No. 4, 5A, 5B, 6 & 7E, HPSIDC Indl. Area, Baddi, District: Solan, Himachal Pradesh – 173 205.
Manufacturing License Number (Mfg. Lic. No.): MNB/06/291
7. Marketed By
Marketed by: USV Private Limited